NASDAQ:OMCL

Omnicell - OMCL Stock Forecast, Price & News

$54.92

-1.10 (-1.96%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: $54.52
▼
$55.54
50-Day Range: $51.51
▼
$60.43
52-Week Range: $46.11
▼
$134.37

Volume: 359,204 shs
Average Volume: 486,504 shs
Market Capitalization: $2.47 billion

P/E Ratio: 549.20
Dividend Yield: N/A
Price Target: $71.67

Institutional Ownership

Omnicell MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 30.5% Upside
$71.67 Price Target
Short Interest: Bearish
5.87% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.59
Based on 7 Articles This Week
Insider Trading: Selling Shares
$756,982 Sold Last Quarter
Proj. Earnings Growth: 142.31%
From $0.52 to $1.26 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.47 out of 5 stars

Medical Sector

152nd out of 989 stocks

Electronic Computers Industry

2nd out of 5 stocks

4.4

Analyst's Opinion

Consensus Rating
Omnicell has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $71.67, Omnicell has a forecasted upside of 30.5% from its current price of $54.92.
Amount of Analyst Coverage
Omnicell has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.0

Short Interest

Percentage of Shares Shorted
5.87% of the outstanding shares of Omnicell have been sold short.
Short Interest Ratio / Days to Cover
Omnicell has a short interest ratio ("days to cover") of 4.9.
Change versus previous month
Short interest in Omnicell has recently decreased by 4.69%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Omnicell does not currently pay a dividend.
Dividend Growth
Omnicell does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OMCL.

2.6

News and Social Media Coverage

News Sentiment
Omnicell has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Omnicell this week, compared to 3 articles on an average week.
Search Interest
Only 4 people have searched for OMCL on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Omnicell insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $756,982.00 in company stock.
Percentage Held by Insiders
Only 2.76% of the stock of Omnicell is held by insiders.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Omnicell are expected to grow by 142.31% in the coming year, from $0.52 to $1.26 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Omnicell is 549.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 119.78.
Price to Earnings Ratio vs. Sector
The P/E ratio of Omnicell is 549.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 134.20.
Price to Earnings Growth Ratio
Omnicell has a PEG Ratio of 8.15. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Omnicell has a P/B Ratio of 2.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Omnicell (NASDAQ:OMCL) Stock

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Santa Clara, CA.

Receive OMCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omnicell and its competitors with MarketBeat's FREE daily newsletter.

OMCL Stock News Headlines

March 23, 2023 | americanbankingnews.com

Omnicell, Inc. (NASDAQ:OMCL) Receives $73.88 Average Target Price from Brokerages

March 20, 2023 | finance.yahoo.com

Should You Hold Omnicell (OMCL)?

March 24, 2023 | Oxford Club (Ad)

My No. 1 dividend stock for a LIFETIME of income.

Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.

March 17, 2023 | finance.yahoo.com

Should You Hold Omnicell (OMCL) for the Long-Term?

March 3, 2023 | finance.yahoo.com

Omnicell, Inc. (NASDAQ:OMCL) Q4 2022 Earnings Call Transcript

February 27, 2023 | 247wallst.com

First Look Analysts Research Calls for Monday, February 27

February 16, 2023 | finance.yahoo.com

CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

February 15, 2023 | businesswire.com

Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

March 24, 2023 | Oxford Club (Ad)

My No. 1 dividend stock for a LIFETIME of income.

Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.

February 15, 2023 | finance.yahoo.com

Omnicell, Inc.'s (NASDAQ:OMCL) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

February 6, 2023 | finance.yahoo.com

Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline

January 22, 2023 | seekingalpha.com

Omnicell: Poor Track Record, Staying On The Sidelines

January 19, 2023 | finance.yahoo.com

These 4 Toxic Stocks May Bring Bad Luck to Your Portfolio

January 17, 2023 | finance.yahoo.com

Do Options Traders Know Something About Omnicell (OMCL) Stock We Don't?

January 16, 2023 | finance.yahoo.com

What Does Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Indicate?

January 5, 2023 | finance.yahoo.com

Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 4, 2023 | finance.yahoo.com

5 Toxic Stocks That Can Set Off Alarm Bells for Your Portfolio

January 3, 2023 | finance.yahoo.com

Omnicell (OMCL) Failed to Meet Expectations in Q3

December 28, 2022 | finance.yahoo.com

Omnicell (OMCL) Ailed by Mounting Costs, Macroeconomic Issues

December 21, 2022 | finance.yahoo.com

Should You Hold Omnicell (OMCL) Stock?

December 21, 2022 | finance.yahoo.com

There's Been No Shortage Of Growth Recently For Omnicell's (NASDAQ:OMCL) Returns On Capital

December 18, 2022 | finance.yahoo.com

Omnicell (OMCL) Stock Declined on Management Guidance

December 5, 2022 | finance.yahoo.com

Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022

November 24, 2022 | finance.yahoo.com

Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference

November 23, 2022 | finance.yahoo.com

Omnicell (NASDAQ:OMCL) stock falls 6.4% in past week as one-year earnings and shareholder returns continue downward trend

November 9, 2022 | finance.yahoo.com

Omnicell Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag

November 7, 2022 | finance.yahoo.com

Omnicell (OMCL) Q3 Earnings Beat Estimates, Guidance Cut

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive OMCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omnicell and its competitors with MarketBeat's FREE daily newsletter.

OMCL Company Calendar

Last Earnings: 11/02/2021
Today: 3/24/2023
Next Earnings (Estimated): 4/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electronic computers
Sub-Industry: Health Care Technology
Sector: Medical
Current Symbol: NASDAQ:OMCL
CUSIP: 68213N10
CIK: 926326
Web: www.omnicell.com
Phone: (650) 251-6100
Fax: 847-596-3402
Employees: 4,230
Year Founded: 1992

Price Target and Rating

Average Stock Price Forecast: $71.67
High Stock Price Forecast: $120.00
Low Stock Price Forecast: $54.00
Forecasted Upside/Downside: +30.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 8 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.10
Trailing P/E Ratio: 549.20
Forward P/E Ratio: 105.62
P/E Growth: 8.15
Net Income: $5.65 million
Net Margins: 0.44%
Pretax Margin: -0.19%
Return on Equity: 7.11%
Return on Assets: 3.65%

Debt

Debt-to-Equity Ratio: 0.50
Current Ratio: 2.06
Quick Ratio: 1.71

Sales & Book Value

Annual Sales: $1.30 billion
Price / Sales: 1.91
Cash Flow: $3.92 per share
Price / Cash Flow: 14.02
Book Value: $25.52 per share
Price / Book: 2.15

Miscellaneous

Outstanding Shares: 44,990,000
Free Float: 43,746,000
Market Cap: $2.47 billion
Optionable: Optionable
Beta: 0.89

Social Links

Key Executives

Randall A. Lipps
Chairman, President & Chief Executive Officer

Peter J. Kuipers
Chief Financial Officer & Executive Vice President

Giri Chodavarapu
Chief Information Officer

Virad Gupta
Chief Technology Officer & Senior Vice President

Roxanne Turner
Chief Compliance & Privacy Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

OMCL Stock - Frequently Asked Questions

Should I buy or sell Omnicell stock right now?: 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last twelve months. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" OMCL shares.
View OMCL analyst ratings or view top-rated stocks.
What is Omnicell's stock price forecast for 2023?: 8 brokerages have issued 12-month target prices for Omnicell's stock. Their OMCL share price forecasts range from $54.00 to $120.00. On average, they anticipate the company's stock price to reach $71.67 in the next year. This suggests a possible upside of 30.5% from the stock's current price.
View analysts price targets for OMCL or view top-rated stocks among Wall Street analysts.
How have OMCL shares performed in 2023?: Omnicell's stock was trading at $50.42 at the start of the year. Since then, OMCL stock has increased by 8.9% and is now trading at $54.92.
View the best growth stocks for 2023 here.
When is Omnicell's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our OMCL earnings forecast.
How were Omnicell's earnings last quarter?: Omnicell, Inc. (NASDAQ:OMCL) issued its quarterly earnings data on Tuesday, November, 2nd. The company reported $1.08 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.45. The company had revenue of $296.40 million for the quarter, compared to analyst estimates of $283.82 million. Omnicell had a trailing twelve-month return on equity of 7.11% and a net margin of 0.44%. During the same period last year, the business posted $0.40 EPS.
What ETFs hold Omnicell's stock?: ETFs with the largest weight of Omnicell (NASDAQ:OMCL) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Robotics & Automation ETF (ROBO), Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ), Invesco Nasdaq Future Gen 200 ETF (QQQS), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC) and First Trust Multi-Manager Small Cap Opportunities ETF (MMSC).
What guidance has Omnicell issued on next quarter's earnings?: Omnicell issued an update on its first quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of $0.04-$0.14 for the period, compared to the consensus estimate of $0.19. The company issued revenue guidance of $273.00 million-$283.00 million, compared to the consensus revenue estimate of $275.46 million.
What is Randall A. Lipps' approval rating as Omnicell's CEO?: 150 employees have rated Omnicell Chief Executive Officer Randall A. Lipps on Glassdoor.com. Randall A. Lipps has an approval rating of 68% among the company's employees.

What other stocks do shareholders of Omnicell own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Adobe (ADBE), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Alibaba Group (BABA) and Intel (INTC).
What is Omnicell's stock symbol?: Omnicell trades on the NASDAQ under the ticker symbol "OMCL."
Who are Omnicell's major shareholders?: Omnicell's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.64%), Clearbridge Investments LLC (2.65%), Geneva Capital Management LLC (2.17%), ArrowMark Colorado Holdings LLC (1.92%), Geode Capital Management LLC (1.89%) and Dimensional Fund Advisors LP (1.71%). Insiders that own company stock include Christine Marie Mellon, Dan S Johnston, James T Judson, Joanne B Bauer, Joseph Brian Spears, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann.
View institutional ownership trends.
How do I buy shares of Omnicell?: Shares of OMCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Omnicell's stock price today?: One share of OMCL stock can currently be purchased for approximately $54.92.
How much money does Omnicell make?: Omnicell (NASDAQ:OMCL) has a market capitalization of $2.47 billion and generates $1.30 billion in revenue each year. The company earns $5.65 million in net income (profit) each year or $0.10 on an earnings per share basis.
How many employees does Omnicell have?: The company employs 4,230 workers across the globe.
Does Omnicell have any subsidiaries?: The following companies are subsidiares of Omnicell: 340B Investment LLC, 340B Link Business, 340B Link LLC, 340B Solutions LLC, Aesynt, Ateb Inc., FDS Amplicare, FDS Amplicare Company, FDS Inc., FDS Insurance Agency Inc., Flavma Inc., InPharmics, MTS Medication Technologies Inc., MTS Medication Technologies Inc., MTS Packaging Systems Inc., MarkeTouch Media LLC, MarkeTouch Media LLC, MedPak Holdings Inc., Omnicell (Beijing) Technology Co. Ltd, Omnicell B.V., Omnicell GmbH, Omnicell India Private Limited, Omnicell International LLC, Omnicell Limited, Omnicell Pty Ltd, Omnicell S.r.l., Omnicell SAS, ReCept Cityview LLC, ReCept F&M LLC, ReCept Group Inc., ReCept Healthcare Services L.P., ReCept Holdings Inc., ReCept LLC, ReCept One LLC, ReCept Pharmacy, ReCept Pharmacy L.P., RxInnovation Inc., and ateb Inc..
Read More
How can I contact Omnicell?: Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The official website for the company is www.omnicell.com. The company can be reached via phone at (650) 251-6100, via email at ir@omnicell.com, or via fax at 847-596-3402.

This page (NASDAQ:OMCL) was last updated on 3/24/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Omnicell - OMCL Stock Forecast, Price & News

Omnicell MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Omnicell (NASDAQ:OMCL) Stock

OMCL Stock News Headlines

OMCL Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

OMCL Stock - Frequently Asked Questions

Overall MarketRank^™